Biotechnology
The Biotechnology industry has a total of 681 stocks, with a combined market cap of $1,375.26 billion and total revenue of $120.55 billion.
Market Cap
1,375.26B
Revenue
120.55B
Profits
-34.27B
PE Ratio
n/a
Profit Margin
-28.43%
Dividend Yield
0.10%
681 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 550.22B | 0.84% | 3,202,847 | 33.32B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 102.67B | -0.06% | 677,777 | 9.87B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 95.34B | -0.84% | 502,941 | 13.12B |
| 4 | MRNA | Moderna, Inc. | 41.34B | 1.69% | 2,227,957 | 6.85B |
| 5 | ARGX | argenx SE | 22.16B | 1.14% | 228,781 | 39.48M |
| 6 | BNTX | BioNTech SE | 20.73B | 0.58% | 348,295 | 4.24B |
| 7 | GMAB | Genmab A/S | 18.40B | 2.51% | 339,609 | 2.44B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 18.12B | -0.28% | 473,005 | 1.83B |
| 9 | BGNE | BeiGene, Ltd. | 16.32B | 3.38% | 204,920 | 2.46B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 15.35B | -1.53% | 2,252,754 | 2.47B |
| 11 | SKYE | Skye Bioscience, Inc. | 12.63B | 1.17% | 31,336 | - |
| 12 | RPRX | Royalty Pharma plc | 12.51B | -0.39% | 1,307,461 | 2.35B |
| 13 | SRPT | Sarepta Therapeutics, Inc. | 12.09B | 1.08% | 956,749 | 1.24B |
| 14 | INCY | Incyte Corporation | 11.60B | 0.98% | 1,522,989 | 3.70B |
| 15 | UTHR | United Therapeutics Corporation | 11.00B | -0.89% | 355,916 | 2.33B |
| 16 | TECH | Bio-Techne Corporation | 10.07B | 2.23% | 946,213 | 1.14B |
| 17 | ROIV | Roivant Sciences Ltd. | 8.89B | 1.38% | 3,107,787 | 123.24M |
| 18 | LEGN | Legend Biotech Corporation | 8.24B | 1.98% | 887,242 | 285.14M |
| 19 | VKTX | Viking Therapeutics, Inc. | 8.13B | 7.91% | 3,479,935 | - |
| 20 | CERE | Cerevel Therapeutics Holdings, Inc. | 7.71B | 0.95% | 673,871 | - |
| 21 | ASND | Ascendis Pharma A/S | 7.69B | -0.75% | 225,238 | 296.35M |
| 22 | EXEL | Exelixis, Inc. | 6.99B | 0.72% | 1,539,388 | 1.83B |
| 23 | CYTK | Cytokinetics, Incorporated | 6.83B | 0.83% | 607,960 | 7.53M |
| 24 | JAZZ | Jazz Pharmaceuticals plc | 6.82B | 1.89% | 476,129 | 3.83B |
| 25 | PCVX | Vaxcyte, Inc. | 6.60B | 1.10% | 583,957 | - |
| 26 | IONS | Ionis Pharmaceuticals, Inc. | 6.06B | -0.60% | 540,395 | 787.65M |
| 27 | APLS | Apellis Pharmaceuticals, Inc. | 6.01B | 4.03% | 959,841 | 396.59M |
| 28 | RVMD | Revolution Medicines, Inc. | 5.92B | 1.78% | 1,197,506 | 11.58M |
| 29 | BPMC | Blueprint Medicines Corporation | 5.69B | 2.50% | 710,386 | 249.38M |
| 30 | IBRX | ImmunityBio, Inc. | 4.95B | 43.84% | 39,079,607 | 622.00K |
| 31 | HALO | Halozyme Therapeutics, Inc. | 4.90B | 0.29% | 525,090 | 829.25M |
| 32 | BBIO | BridgeBio Pharma, Inc. | 4.59B | 2.26% | 1,017,617 | 9.30M |
| 33 | CRSP | CRISPR Therapeutics AG | 4.58B | 0.34% | 1,323,232 | 371.21M |
| 34 | KRYS | Krystal Biotech, Inc. | 4.44B | 0.77% | 162,227 | 50.70M |
| 35 | NUVL | Nuvalent, Inc. | 4.28B | 1.20% | 225,286 | - |
| 36 | ALPN | Alpine Immune Sciences, Inc. | 4.23B | -0.09% | 1,325,763 | 58.88M |
| 37 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.06B | -0.54% | 450,985 | - |
| 38 | IMVT | Immunovant, Inc. | 3.95B | -2.09% | 1,397,016 | - |
| 39 | INSM | Insmed Incorporated | 3.68B | -0.48% | 1,213,011 | 305.21M |
| 40 | RARE | Ultragenyx Pharmaceutical Inc. | 3.64B | 0.89% | 439,929 | 434.25M |
| 41 | AXSM | Axsome Therapeutics, Inc. | 3.40B | 0.27% | 264,277 | 270.60M |
| 42 | SWTX | SpringWorks Therapeutics, Inc. | 3.36B | 3.01% | 864,318 | 5.45M |
| 43 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.28B | -0.40% | 551,185 | 4.01M |
| 44 | IOVA | Iovance Biotherapeutics, Inc. | 3.25B | 0.87% | 2,433,841 | 1.19M |
| 45 | FTRE | Fortrea Holdings Inc. | 3.25B | - | 409,199 | 3.11B |
| 46 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.18B | 1.12% | 938,012 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 3.06B | 1.00% | 312,186 | - |
| 48 | FOLD | Amicus Therapeutics, Inc. | 3.04B | 1.08% | 1,675,970 | 399.36M |
| 49 | IDYA | IDEAYA Biosciences, Inc. | 2.99B | 3.42% | 607,109 | 23.39M |
| 50 | IMCR | Immunocore Holdings plc | 2.91B | 0.79% | 402,526 | 249.43M |
| 51 | ACAD | ACADIA Pharmaceuticals Inc. | 2.75B | 2.45% | 1,113,331 | 726.44M |
| 52 | ACLX | Arcellx, Inc. | 2.74B | 1.05% | 328,804 | 110.32M |
| 53 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.74B | 1.14% | 601,220 | 181.74M |
| 54 | CGON | CG Oncology, Inc. | 2.73B | 13.26% | 818,117 | 204.00K |
| 55 | MOR | MorphoSys AG | 2.72B | -0.50% | 387,484 | 264.75M |
| 56 | SMMT | Summit Therapeutics Inc. | 2.71B | 8.73% | 1,377,163 | - |
| 57 | APGE | Apogee Therapeutics, Inc. | 2.66B | 2.77% | 235,473 | - |
| 58 | MLTX | MoonLake Immunotherapeutics | 2.65B | 0.57% | 217,946 | - |
| 59 | MRUS | Merus N.V. | 2.61B | 0.24% | 819,061 | 43.95M |
| 60 | JANX | Janux Therapeutics, Inc. | 2.45B | 0.62% | 571,989 | 8.08M |
| 61 | CORT | Corcept Therapeutics Incorporated | 2.36B | 2.66% | 776,588 | 482.38M |
| 62 | CLDX | Celldex Therapeutics, Inc. | 2.34B | 0.11% | 317,105 | 6.88M |
| 63 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.30B | 0.34% | 296,523 | 77.43M |
| 64 | GERN | Geron Corporation | 2.23B | 6.46% | 7,855,222 | 237.00K |
| 65 | VCEL | Vericel Corporation | 2.23B | 1.32% | 268,790 | 197.52M |
| 66 | ARVN | Arvinas, Inc. | 2.21B | 2.44% | 765,540 | 78.50M |
| 67 | DNLI | Denali Therapeutics Inc. | 2.20B | 3.14% | 1,093,786 | 330.53M |
| 68 | PTCT | PTC Therapeutics, Inc. | 2.19B | 12.08% | 1,500,515 | 927.56M |
| 69 | VERA | Vera Therapeutics, Inc. | 2.18B | 2.48% | 822,396 | - |
| 70 | KROS | Keros Therapeutics, Inc. | 2.08B | 6.77% | 284,633 | 151.00K |
| 71 | TGTX | TG Therapeutics, Inc. | 2.08B | -3.16% | 2,804,907 | 233.66M |
| 72 | KYMR | Kymera Therapeutics, Inc. | 2.04B | 0.06% | 447,088 | 78.59M |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.01B | 4.37% | 610,588 | - |
| 74 | NTLA | Intellia Therapeutics, Inc. | 2.00B | 3.70% | 994,220 | 36.28M |
| 75 | RCKT | Rocket Pharmaceuticals, Inc. | 1.99B | -0.54% | 858,483 | - |
| 76 | NAMS | NewAmsterdam Pharma Company N.V. | 1.96B | 2.57% | 62,241 | 15.66M |
| 77 | RNA | Avidity Biosciences, Inc. | 1.94B | 2.22% | 1,026,076 | 9.56M |
| 78 | SANA | Sana Biotechnology, Inc. | 1.92B | 2.59% | 1,588,278 | - |
| 79 | GLPG | Galapagos NV | 1.90B | 0.45% | 74,898 | 266.36M |
| 80 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | 3.57% | 4,320,149 | 44.58M |
| 81 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.85B | 10.60% | 71,157,495 | 251.46M |
| 82 | FUSN | Fusion Pharmaceuticals Inc. | 1.82B | 0.09% | 351,175 | 2.07M |
| 83 | GPCR | Structure Therapeutics Inc. | 1.81B | -0.10% | 967,460 | - |
| 84 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 2.38% | 650,563 | - |
| 85 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.75B | 1.43% | 772,159 | 398.20M |
| 86 | AGIO | Agios Pharmaceuticals, Inc. | 1.75B | -0.57% | 407,162 | 26.82M |
| 87 | BEAM | Beam Therapeutics Inc. | 1.75B | -1.02% | 1,080,777 | 377.71M |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 1.66B | 1.35% | 368,849 | 582.02M |
| 89 | INBX | Inhibrx, Inc. | 1.61B | -0.09% | 189,853 | 1.80M |
| 90 | ZLAB | Zai Lab Limited | 1.57B | 1.08% | 362,617 | 266.72M |
| 91 | ADMA | ADMA Biologics, Inc. | 1.52B | 1.71% | 1,536,662 | 258.22M |
| 92 | EWTX | Edgewise Therapeutics, Inc. | 1.51B | 1.44% | 663,293 | - |
| 93 | KURA | Kura Oncology, Inc. | 1.50B | 3.42% | 543,365 | - |
| 94 | ARDX | Ardelyx, Inc. | 1.49B | 1.74% | 5,464,149 | 124.46M |
| 95 | PTGX | Protagonist Therapeutics, Inc. | 1.47B | 1.99% | 357,577 | 60.00M |
| 96 | GYRE | Gyre Therapeutics, Inc. | 1.46B | 4.78% | 190,123 | 113.45M |
| 97 | NMRA | Neumora Therapeutics, Inc. | 1.45B | 0.99% | 676,263 | - |
| 98 | RCUS | Arcus Biosciences, Inc. | 1.41B | 5.57% | 494,575 | 117.00M |
| 99 | MORF | Morphic Holding, Inc. | 1.40B | 0.32% | 523,135 | - |
| 100 | AKRO | Akero Therapeutics, Inc. | 1.36B | 4.28% | 752,971 | - |
| 101 | DAWN | Day One Biopharmaceuticals, Inc. | 1.30B | 12.94% | 3,599,821 | - |
| 102 | SLNO | Soleno Therapeutics, Inc. | 1.27B | 1.47% | 133,494 | - |
| 103 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.26B | 1.53% | 283,298 | 301.77M |
| 104 | PHVS | Pharvaris N.V. | 1.26B | 2.55% | 84,698 | - |
| 105 | LGND | Ligand Pharmaceuticals Incorporated | 1.25B | 0.28% | 85,640 | - |
| 106 | VRNA | Verona Pharma plc | 1.24B | 1.05% | 260,511 | - |
| 107 | XNCR | Xencor, Inc. | 1.22B | 3.90% | 355,716 | 168.34M |
| 108 | SYRE | Spyre Therapeutics, Inc. | 1.21B | 3.36% | 225,275 | 886.00K |
| 109 | TARS | Tarsus Pharmaceuticals, Inc. | 1.20B | -0.53% | 366,893 | 17.45M |
| 110 | FDMT | 4D Molecular Therapeutics, Inc. | 1.19B | -1.19% | 317,415 | 20.72M |
| 111 | BLTE | Belite Bio, Inc | 1.18B | 3.57% | 46,599 | - |
| 112 | SRRK | Scholar Rock Holding Corporation | 1.16B | 4.08% | 473,359 | - |
| 113 | MNKD | MannKind Corporation | 1.14B | 1.20% | 1,826,008 | 198.96M |
| 114 | MIRM | Mirum Pharmaceuticals, Inc. | 1.14B | -0.12% | 257,389 | 186.37M |
| 115 | PRTA | Prothena Corporation plc | 1.12B | 1.51% | 363,287 | 91.37M |
| 116 | VIR | Vir Biotechnology, Inc. | 1.12B | 7.86% | 1,088,589 | 86.18M |
| 117 | ABCL | AbCellera Biologics Inc. | 1.10B | 3.58% | 1,364,552 | 38.03M |
| 118 | CGEM | Cullinan Oncology, Inc. | 1.09B | 31.43% | 4,731,809 | - |
| 119 | IMTX | Immatics N.V. | 1.03B | 2.35% | 290,330 | 60.00M |
| 120 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.02B | 1.58% | 1,260,108 | 288.95M |
| 121 | ABVX | Abivax SA | 992.84M | 0.25% | 53,721 | 5.13M |
| 122 | SLN | Silence Therapeutics plc | 986.66M | -0.07% | 125,543 | 32.12M |
| 123 | ARQT | Arcutis Biotherapeutics, Inc. | 973.80M | -1.40% | 2,142,127 | 59.61M |
| 124 | SAVA | Cassava Sciences, Inc. | 965.65M | 2.81% | 1,061,170 | - |
| 125 | INVA | Innoviva, Inc. | 964.85M | 1.80% | 279,142 | 310.46M |
| 126 | BCYC | Bicycle Therapeutics plc | 964.47M | 0.84% | 137,278 | 26.98M |
| 127 | LQDA | Liquidia Corporation | 952.63M | 1.29% | 515,948 | 17.49M |
| 128 | PRAX | Praxis Precision Medicines, Inc. | 936.42M | 3.63% | 133,868 | 2.45M |
| 129 | MDXG | MiMedx Group, Inc. | 925.35M | 0.40% | 604,766 | 321.48M |
| 130 | MGNX | MacroGenics, Inc. | 903.15M | 1.32% | 649,082 | 58.75M |
| 131 | CNTA | Centessa Pharmaceuticals plc | 881.07M | -0.11% | 254,924 | 6.85M |
| 132 | BCRX | BioCryst Pharmaceuticals, Inc. | 857.58M | - | 2,219,955 | 331.41M |
| 133 | ALXO | ALX Oncology Holdings Inc. | 851.41M | -0.06% | 461,889 | - |
| 134 | RLAY | Relay Therapeutics, Inc. | 835.61M | 3.49% | 745,224 | 25.55M |
| 135 | EYPT | EyePoint Pharmaceuticals, Inc. | 834.67M | 3.65% | 1,140,190 | 46.02M |
| 136 | TYRA | Tyra Biosciences, Inc. | 823.05M | 3.71% | 76,678 | - |
| 137 | SAGE | Sage Therapeutics, Inc. | 822.86M | 0.81% | 1,461,453 | 91.06M |
| 138 | VRDN | Viridian Therapeutics, Inc. | 808.45M | 1.42% | 523,659 | 314.00K |
| 139 | SPRY | ARS Pharmaceuticals, Inc. | 805.79M | 3.21% | 511,249 | 30.00K |
| 140 | ELVN | Enliven Therapeutics, Inc. | 804.12M | 2.38% | 147,785 | - |
| 141 | TNGX | Tango Therapeutics, Inc. | 793.98M | 1.50% | 291,143 | 36.53M |
| 142 | RGNX | REGENXBIO Inc. | 793.19M | 0.81% | 298,490 | 90.24M |
| 143 | ZNTL | Zentalis Pharmaceuticals, Inc. | 784.82M | 0.68% | 471,892 | - |
| 144 | ETNB | 89bio, Inc. | 772.32M | 0.12% | 639,138 | - |
| 145 | PRTC | PureTech Health plc | 770.10M | 2.24% | 100 | 3.33M |
| 146 | CRGX | CARGO Therapeutics, Inc. | 735.30M | 2.19% | 85,619 | - |
| 147 | NRIX | Nurix Therapeutics, Inc. | 733.16M | - | 599,462 | 80.89M |
| 148 | ARCT | Arcturus Therapeutics Holdings Inc. | 714.60M | 1.45% | 259,933 | 166.80M |
| 149 | PLRX | Pliant Therapeutics, Inc. | 712.36M | -0.59% | 359,681 | 1.58M |
| 150 | LBPH | Longboard Pharmaceuticals, Inc. | 710.26M | 2.44% | 175,909 | - |
| 151 | AUPH | Aurinia Pharmaceuticals Inc. | 710.07M | 0.82% | 967,928 | 175.51M |
| 152 | OCUL | Ocular Therapeutix, Inc. | 705.24M | 12.98% | 3,879,503 | 58.44M |
| 153 | AUTL | Autolus Therapeutics plc | 696.41M | -1.96% | 2,739,098 | 1.70M |
| 154 | ENGN | enGene Holdings Inc. | 683.56M | 5.30% | 113,376 | - |
| 155 | IRON | Disc Medicine, Inc. | 679.96M | 3.88% | 363,062 | - |
| 156 | MESO | Mesoblast Limited | 678.51M | 1.46% | 323,825 | 7.25M |
| 157 | PHAR | Pharming Group N.V. | 678.49M | 2.08% | 1,703 | 272.57M |
| 158 | KYTX | Kyverna Therapeutics, Inc. | 666.99M | -2.95% | 705,577 | - |
| 159 | STOK | Stoke Therapeutics, Inc. | 646.78M | 6.16% | 891,942 | 8.78M |
| 160 | YMAB | Y-mAbs Therapeutics, Inc. | 643.96M | -0.88% | 178,991 | 84.82M |
| 161 | HLVX | HilleVax, Inc. | 635.67M | 6.41% | 366,334 | - |
| 162 | DNTH | Dianthus Therapeutics, Inc. | 630.96M | 2.43% | 75,496 | 2.83M |
| 163 | SVRA | Savara Inc. | 609.23M | -0.90% | 396,502 | - |
| 164 | AVTE | Aerovate Therapeutics, Inc. | 606.02M | 0.83% | 73,309 | - |
| 165 | MNMD | Mind Medicine (MindMed) Inc. | 600.67M | - | 649,198 | - |
| 166 | MLYS | Mineralys Therapeutics, Inc. | 589.12M | 7.52% | 64,688 | - |
| 167 | IMNM | Immunome, Inc. | 586.68M | -3.72% | 966,152 | 14.02M |
| 168 | NUVB | Nuvation Bio Inc. | 584.36M | 2.29% | 628,781 | - |
| 169 | ZYME | Zymeworks Inc. | 582.89M | 1.85% | 253,878 | 76.01M |
| 170 | COGT | Cogent Biosciences, Inc. | 575.59M | 0.17% | 912,095 | - |
| 171 | NVAX | Novavax, Inc. | 572.41M | 3.54% | 2,986,627 | 983.71M |
| 172 | WVE | Wave Life Sciences Ltd. | 569.84M | -1.69% | 396,682 | 113.31M |
| 173 | ANAB | AnaptysBio, Inc. | 562.03M | 11.29% | 643,320 | 17.16M |
| 174 | OLMA | Olema Pharmaceuticals, Inc. | 556.35M | 1.22% | 420,674 | - |
| 175 | IGMS | IGM Biosciences, Inc. | 554.11M | 22.88% | 467,408 | 2.13M |
| 176 | LYEL | Lyell Immunopharma, Inc. | 553.21M | -1.36% | 343,130 | 130.00K |
| 177 | GHRS | GH Research PLC | 546.82M | 0.10% | 19,945 | - |
| 178 | ORIC | ORIC Pharmaceuticals, Inc. | 543.72M | 5.22% | 394,333 | - |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 536.82M | 0.88% | 365,057 | 682.00K |
| 180 | VALN | Valneva SE | 531.55M | 1.33% | 38,173 | 170.79M |
| 181 | PRME | Prime Medicine, Inc. | 530.73M | 2.91% | 631,755 | - |
| 182 | OABI | OmniAb, Inc. | 524.72M | 1.13% | 575,939 | 34.16M |
| 183 | CALT | Calliditas Therapeutics AB (publ) | 523.32M | 1.57% | 3,787 | 119.73M |
| 184 | CVAC | CureVac N.V. | 521.65M | 0.87% | 837,430 | 59.73M |
| 185 | ABSI | Absci Corporation | 517.92M | 2.81% | 636,613 | 5.72M |
| 186 | AVBP | ArriVent BioPharma, Inc. | 517.14M | -0.64% | 53,086 | - |
| 187 | CABA | Cabaletta Bio, Inc. | 515.32M | -9.61% | 2,907,886 | - |
| 188 | ALT | Altimmune, Inc. | 514.70M | 0.83% | 2,230,136 | 426.00K |
| 189 | EXAI | Exscientia plc | 506.58M | 1.00% | 384,502 | 25.42M |
| 190 | KRRO | Korro Bio, Inc. | 504.82M | 7.52% | 28,091 | - |
| 191 | STTK | Shattuck Labs, Inc. | 502.76M | 8.28% | 381,451 | 1.66M |
| 192 | ALEC | Alector, Inc. | 502.68M | 9.15% | 448,590 | 97.06M |
| 193 | ATXS | Astria Therapeutics, Inc. | 494.22M | -1.85% | 1,099,020 | - |
| 194 | ANNX | Annexon, Inc. | 493.90M | 2.40% | 1,422,324 | - |
| 195 | ALLO | Allogene Therapeutics, Inc. | 493.39M | 1.23% | 2,424,911 | 95.00K |
| 196 | ABUS | Arbutus Biopharma Corporation | 491.88M | 0.37% | 400,532 | 18.14M |
| 197 | APLT | Applied Therapeutics, Inc. | 488.96M | 1.18% | 429,193 | 9.99M |
| 198 | PROK | ProKidney Corp. | 487.43M | -21.77% | 1,523,782 | - |
| 199 | CELC | Celcuity Inc. | 484.81M | 0.95% | 667,710 | - |
| 200 | NKTX | Nkarta, Inc. | 484.11M | 0.73% | 974,066 | - |
| 201 | VERV | Verve Therapeutics, Inc. | 483.86M | -0.96% | 767,147 | 11.76M |
| 202 | URGN | UroGen Pharma Ltd. | 482.83M | 2.39% | 134,451 | 82.71M |
| 203 | HUMA | Humacyte, Inc. | 475.15M | 2.31% | 681,036 | - |
| 204 | CDMO | Avid Bioservices, Inc. | 464.81M | 0.41% | 1,255,084 | 136.74M |
| 205 | KALV | KalVista Pharmaceuticals, Inc. | 454.79M | 2.76% | 233,587 | - |
| 206 | TSHA | Taysha Gene Therapies, Inc. | 446.97M | 3.91% | 888,986 | 15.45M |
| 207 | FULC | Fulcrum Therapeutics, Inc. | 442.22M | 0.14% | 261,291 | 2.81M |
| 208 | THRD | Third Harmonic Bio, Inc. | 441.40M | 3.54% | 75,788 | - |
| 209 | OCS | Oculis Holding AG | 440.53M | -0.25% | 88,399 | 1.05M |
| 210 | TBPH | Theravance Biopharma, Inc. | 439.26M | -0.22% | 257,021 | 57.42M |
| 211 | EDIT | Editas Medicine, Inc. | 437.49M | 1.92% | 1,334,238 | 78.12M |
| 212 | FATE | Fate Therapeutics, Inc. | 432.50M | -1.81% | 2,727,872 | 63.53M |
| 213 | CCCC | C4 Therapeutics, Inc. | 423.27M | -1.12% | 1,046,912 | 20.76M |
| 214 | TRDA | Entrada Therapeutics, Inc. | 418.33M | 0.73% | 24,519 | 129.01M |
| 215 | VYGR | Voyager Therapeutics, Inc. | 413.77M | 2.70% | 342,440 | 250.01M |
| 216 | SLRN | Acelyrin, Inc. | 412.72M | - | 650,311 | - |
| 217 | LXEO | Lexeo Therapeutics, Inc. | 411.85M | 2.80% | 376,712 | - |
| 218 | LRMR | Larimar Therapeutics, Inc. | 410.87M | 1.74% | 127,626 | - |
| 219 | TRML | Tourmaline Bio, Inc. | 402.14M | -2.00% | 358,957 | - |
| 220 | LENZ | LENZ Therapeutics, Inc. | 401.39M | 1.75% | 200,318 | - |
| 221 | TVTX | Travere Therapeutics, Inc. | 400.28M | -2.41% | 1,200,446 | 145.24M |
| 222 | CTNM | Contineum Therapeutics, Inc. | 395.06M | -1.69% | 18,854 | 50.00M |
| 223 | REPL | Replimune Group, Inc. | 394.11M | 4.39% | 576,569 | - |
| 224 | CBUS | Cibus, Inc. | 392.28M | 1.48% | 34,855 | 1.82M |
| 225 | LXRX | Lexicon Pharmaceuticals, Inc. | 389.05M | 2.60% | 1,252,703 | 1.20M |
| 226 | ITOS | iTeos Therapeutics, Inc. | 387.11M | 1.89% | 135,657 | 12.60M |
| 227 | PEPG | PepGen Inc. | 386.41M | 1.97% | 37,892 | - |
| 228 | NGNE | Neurogene Inc. | 385.08M | 0.30% | 47,631 | - |
| 229 | MREO | Mereo BioPharma Group plc | 383.76M | -2.49% | 561,115 | 10.00M |
| 230 | BMEA | Biomea Fusion, Inc. | 381.62M | 2.96% | 581,643 | - |
| 231 | ANRO | Alto Neuroscience, Inc. | 381.21M | 0.35% | 22,730 | - |
| 232 | ADPT | Adaptive Biotechnologies Corporation | 377.24M | -0.38% | 1,058,305 | 170.28M |
| 233 | HRTX | Heron Therapeutics, Inc. | 368.31M | -3.92% | 2,305,733 | 127.04M |
| 234 | RNAC | Cartesian Therapeutics, Inc. | 365.20M | 0.62% | 123,557 | 26.00M |
| 235 | ADCT | ADC Therapeutics SA | 359.41M | -2.25% | 321,167 | 69.56M |
| 236 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 359.39M | 2.24% | 90,155 | - |
| 237 | AURA | Aura Biosciences, Inc. | 357.42M | 1.98% | 113,154 | - |
| 238 | IMMP | Immutep Limited | 355.47M | 1.92% | 876,299 | 4.58M |
| 239 | MRSN | Mersana Therapeutics, Inc. | 354.51M | 3.16% | 851,384 | 36.86M |
| 240 | RVNC | Revance Therapeutics, Inc. | 354.33M | 3.34% | 2,269,826 | 234.04M |
| 241 | PGEN | Precigen, Inc. | 350.98M | 0.71% | 405,343 | 6.23M |
| 242 | SLDB | Solid Biosciences Inc. | 339.06M | 5.15% | 188,735 | - |
| 243 | TNYA | Tenaya Therapeutics, Inc. | 338.40M | 2.13% | 97,385 | - |
| 244 | RANI | Rani Therapeutics Holdings, Inc. | 336.77M | 1.83% | 42,037 | - |
| 245 | CRBU | Caribou Biosciences, Inc. | 335.07M | -1.33% | 1,016,198 | 34.48M |
| 246 | QTTB | Q32 Bio Inc. | 334.26M | -0.78% | 28,370 | 1.16M |
| 247 | FBLG | FibroBiologics, Inc. | 330.79M | -13.44% | 100,696 | - |
| 248 | OCGN | Ocugen, Inc. | 329.38M | 8.47% | 5,356,396 | 6.04M |
| 249 | GUTS | Fractyl Health, Inc. | 320.78M | -0.30% | 111,785 | 120.00K |
| 250 | ATAI | Atai Life Sciences N.V. | 320.43M | 4.89% | 873,501 | 314.00K |
| 251 | TCRX | TScan Therapeutics, Inc. | 319.19M | 0.41% | 92,052 | 21.05M |
| 252 | TERN | Terns Pharmaceuticals, Inc. | 317.44M | 5.82% | 486,978 | - |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 312.25M | 0.54% | 137,512 | - |
| 254 | NAUT | Nautilus Biotechnology, Inc. | 311.49M | 5.51% | 27,717 | - |
| 255 | JSPR | Jasper Therapeutics, Inc. | 307.75M | -3.68% | 52,191 | - |
| 256 | MGTX | MeiraGTx Holdings plc | 305.27M | 1.91% | 72,911 | - |
| 257 | BDTX | Black Diamond Therapeutics, Inc. | 304.62M | 15.26% | 565,080 | - |
| 258 | XOMA | XOMA Corporation | 295.41M | 0.20% | 5,828 | 4.76M |
| 259 | VRCA | Verrica Pharmaceuticals Inc. | 291.43M | 3.31% | 110,101 | 5.12M |
| 260 | CRMD | CorMedix Inc. | 291.05M | 2.31% | 312,826 | - |
| 261 | HOWL | Werewolf Therapeutics, Inc. | 288.48M | 8.70% | 82,000 | 19.94M |
| 262 | ERAS | Erasca, Inc. | 286.32M | 0.53% | 251,882 | - |
| 263 | MGX | Metagenomi, Inc. | 282.17M | 11.72% | 139,170 | 44.76M |
| 264 | LYRA | Lyra Therapeutics, Inc. | 281.99M | -8.70% | 154,788 | 1.56M |
| 265 | RAPT | RAPT Therapeutics, Inc. | 281.86M | 3.85% | 294,633 | - |
| 266 | AKBA | Akebia Therapeutics, Inc. | 280.56M | 0.75% | 2,451,249 | 194.62M |
| 267 | AVXL | Anavex Life Sciences Corp. | 278.08M | 1.47% | 931,815 | - |
| 268 | PRLD | Prelude Therapeutics Incorporated | 275.83M | 0.74% | 17,842 | - |
| 269 | ZURA | Zura Bio Limited | 274.86M | 21.82% | 894,444 | - |
| 270 | INZY | Inozyme Pharma, Inc. | 274.27M | 2.54% | 504,042 | - |
| 271 | INO | Inovio Pharmaceuticals, Inc. | 273.83M | 4.40% | 193,217 | 832.01K |
| 272 | OPT | Opthea Limited | 273.19M | -6.59% | 2,995 | 385.28K |
| 273 | NBTX | Nanobiotix S.A. | 270.42M | -1.03% | 409 | 40.23M |
| 274 | EPIX | ESSA Pharma Inc. | 268.97M | -0.65% | 178,454 | - |
| 275 | GLUE | Monte Rosa Therapeutics, Inc. | 267.32M | -2.20% | 86,169 | - |
| 276 | CYBN | Cybin Inc. | 265.89M | 1.16% | 2,130,767 | - |
| 277 | VNDA | Vanda Pharmaceuticals Inc. | 265.82M | 3.12% | 819,827 | 192.64M |
| 278 | STRO | Sutro Biopharma, Inc. | 263.07M | - | 468,783 | 153.73M |
| 279 | ENTA | Enanta Pharmaceuticals, Inc. | 261.70M | -0.88% | 65,645 | 73.62M |
| 280 | ACRV | Acrivon Therapeutics, Inc. | 261.18M | -0.12% | 276,138 | - |
| 281 | XERS | Xeris Biopharma Holdings, Inc. | 259.44M | 2.94% | 851,125 | 163.91M |
| 282 | CDXC | ChromaDex Corporation | 259.06M | 0.88% | 180,180 | 83.57M |
| 283 | BOLD | Boundless Bio, Inc. | 258.87M | -3.56% | 95,789 | - |
| 284 | IVVD | Invivyd, Inc. | 256.33M | 3.86% | 323,690 | - |
| 285 | PYXS | Pyxis Oncology, Inc. | 249.97M | - | 163,268 | - |
| 286 | FENC | Fennec Pharmaceuticals Inc. | 249.59M | 0.55% | 153,477 | 21.25M |
| 287 | AGEN | Agenus Inc. | 244.86M | 40.84% | 3,353,243 | 156.31M |
| 288 | ADAP | Adaptimmune Therapeutics plc | 244.21M | 1.42% | 1,161,252 | 60.28M |
| 289 | NKTR | Nektar Therapeutics | 242.38M | - | 558,779 | 90.12M |
| 290 | PBYI | Puma Biotechnology, Inc. | 242.00M | 2.87% | 167,402 | 235.64M |
| 291 | XBIT | XBiotech Inc. | 239.65M | -4.14% | 59,095 | - |
| 292 | VSTM | Verastem, Inc. | 237.27M | 1.79% | 42,667 | - |
| 293 | ANL | Adlai Nortye Ltd. | 236.42M | 2.15% | 8,145 | 5.00M |
| 294 | CDT | Conduit Pharmaceuticals Inc. | 234.04M | 0.32% | 5,521 | - |
| 295 | QSI | Quantum-Si incorporated | 233.92M | 2.48% | 352,304 | 1.08M |
| 296 | FHTX | Foghorn Therapeutics Inc. | 233.69M | 4.97% | 34,373 | 34.16M |
| 297 | ALDX | Aldeyra Therapeutics, Inc. | 233.50M | -0.25% | 264,877 | - |
| 298 | ACIU | AC Immune SA | 233.11M | 2.62% | 107,791 | 17.62M |
| 299 | VTYX | Ventyx Biosciences, Inc. | 232.86M | -3.20% | 525,375 | - |
| 300 | CHRS | Coherus BioSciences, Inc. | 231.54M | 5.70% | 901,403 | 257.24M |
| 301 | QURE | uniQure N.V. | 219.88M | -0.22% | 343,044 | 15.84M |
| 302 | RENB | Renovaro Biosciences Inc. | 219.81M | -10.00% | 1,041,768 | - |
| 303 | OVID | Ovid Therapeutics Inc. | 219.20M | 3.68% | 71,121 | 391.70K |
| 304 | TSVT | 2seventy bio, Inc. | 218.33M | -0.82% | 310,994 | 100.39M |
| 305 | LCTX | Lineage Cell Therapeutics, Inc. | 214.93M | 2.70% | 305,552 | 8.95M |
| 306 | MACK | Merrimack Pharmaceuticals, Inc. | 214.05M | - | 54,657 | - |
| 307 | GALT | Galectin Therapeutics Inc. | 213.57M | -1.43% | 173,828 | - |
| 308 | DSGN | Design Therapeutics, Inc. | 211.69M | 0.53% | 106,496 | - |
| 309 | INMB | INmune Bio, Inc. | 211.12M | 4.15% | 77,647 | 155.00K |
| 310 | GTHX | G1 Therapeutics, Inc. | 208.28M | 3.37% | 441,095 | 82.51M |
| 311 | PSTX | Poseida Therapeutics, Inc. | 205.52M | 3.90% | 458,175 | 64.70M |
| 312 | TELO | Telomir Pharmaceuticals, Inc. | 203.27M | -4.45% | 23,888 | - |
| 313 | ATNM | Actinium Pharmaceuticals, Inc. | 201.95M | 4.73% | 202,694 | 81.00K |
| 314 | IPHA | Innate Pharma S.A. | 198.87M | -5.42% | 6,799 | 68.49M |
| 315 | ANVS | Annovis Bio, Inc. | 198.31M | 32.43% | 1,046,474 | - |
| 316 | ZVRA | Zevra Therapeutics, Inc. | 196.29M | - | 155,948 | 27.46M |
| 317 | XFOR | X4 Pharmaceuticals, Inc. | 195.65M | 3.10% | 10,837,407 | - |
| 318 | AEON | AEON Biopharma, Inc. | 193.27M | 19.29% | 132,173 | - |
| 319 | RIGL | Rigel Pharmaceuticals, Inc. | 192.92M | - | 351,535 | 116.88M |
| 320 | GBIO | Generation Bio Co. | 192.78M | -3.65% | 89,527 | 5.90M |
| 321 | ATOS | Atossa Therapeutics, Inc. | 191.72M | 0.66% | 896,406 | - |
| 322 | TRVI | Trevi Therapeutics, Inc. | 191.71M | 9.45% | 53,740 | - |
| 323 | ADVM | Adverum Biotechnologies, Inc. | 190.74M | -2.13% | 763,768 | 3.60M |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 190.45M | -0.63% | 140,531 | - |
| 325 | CADL | Candel Therapeutics, Inc. | 187.53M | -0.62% | 386,083 | - |
| 326 | CDXS | Codexis, Inc. | 187.01M | 0.38% | 510,365 | 70.14M |
| 327 | IPSC | Century Therapeutics, Inc. | 186.98M | -8.57% | 160,996 | 2.24M |
| 328 | VERU | Veru Inc. | 185.90M | 4.96% | 1,277,382 | 15.93M |
| 329 | CLLS | Cellectis S.A. | 185.82M | 0.63% | 222,690 | 24.41M |
| 330 | CMPX | Compass Therapeutics, Inc. | 184.85M | -2.03% | 63,724 | - |
| 331 | OMER | Omeros Corporation | 182.52M | 2.94% | 169,834 | - |
| 332 | OTLK | Outlook Therapeutics, Inc. | 181.96M | 2.93% | 120,024 | - |
| 333 | CRDF | Cardiff Oncology, Inc. | 181.84M | 2.01% | 482,590 | 488.00K |
| 334 | BLUE | bluebird bio, Inc. | 177.86M | 1.13% | 5,125,600 | 21.73M |
| 335 | ELEV | Elevation Oncology, Inc. | 176.12M | -0.69% | 872,449 | - |
| 336 | GNFT | Genfit S.A. | 173.41M | 2.35% | 1,419 | 42.42M |
| 337 | MDWD | MediWound Ltd. | 173.13M | 3.28% | 73,007 | 18.69M |
| 338 | KOD | Kodiak Sciences Inc. | 172.23M | 2.98% | 250,894 | - |
| 339 | CGEN | Compugen Ltd. | 171.90M | 1.05% | 326,170 | 33.46M |
| 340 | CAPR | Capricor Therapeutics, Inc. | 170.43M | 5.05% | 638,686 | 25.18M |
| 341 | IVA | Inventiva S.A. | 170.21M | 2.85% | 24,737 | 25.74M |
| 342 | GLSI | Greenwich LifeSciences, Inc. | 168.96M | 6.32% | 27,889 | - |
| 343 | DRTS | Alpha Tau Medical Ltd. | 167.56M | - | 145,122 | - |
| 344 | TVGN | Tevogen Bio Holdings Inc. | 164.61M | 17.65% | 10,707,241 | - |
| 345 | SCPH | scPharmaceuticals Inc. | 161.88M | 3.22% | 111,838 | 13.59M |
| 346 | RGLS | Regulus Therapeutics Inc. | 158.43M | 6.61% | 204,765 | - |
| 347 | ACHV | Achieve Life Sciences, Inc. | 157.90M | 0.77% | 55,822 | - |
| 348 | OBIO | Orchestra BioMed Holdings, Inc. | 157.06M | -1.13% | 23,643 | 2.76M |
| 349 | PRQR | ProQR Therapeutics N.V. | 156.79M | -1.02% | 49,820 | 10.58M |
| 350 | GOSS | Gossamer Bio, Inc. | 150.69M | -0.30% | 2,083,695 | - |
| 351 | YS | YS Biopharma Co., Ltd. | 150.66M | 0.63% | 39,761 | - |
| 352 | IMAB | I-Mab | 149.38M | -0.55% | 88,536 | 3.90M |
| 353 | CRVO | CervoMed Inc. | 146.98M | -4.68% | 30,978 | 7.14M |
| 354 | ACET | Adicet Bio, Inc. | 138.04M | -7.18% | 1,245,892 | - |
| 355 | RPTX | Repare Therapeutics Inc. | 134.98M | 1.59% | 71,408 | 51.13M |
| 356 | SYRS | Syros Pharmaceuticals, Inc. | 134.71M | -1.18% | 44,487 | 9.94M |
| 357 | DBVT | DBV Technologies S.A. | 131.23M | -0.91% | 41,555 | 15.73M |
| 358 | SGMT | Sagimet Biosciences Inc. | 129.57M | 3.57% | 324,219 | 2.00M |
| 359 | VTGN | VistaGen Therapeutics, Inc. | 128.37M | 1.06% | 194,425 | 1.04M |
| 360 | MOLN | Molecular Partners AG | 127.47M | 6.30% | 254 | 8.38M |
| 361 | VXRT | Vaxart, Inc. | 125.50M | 7.79% | 1,282,096 | 7.38M |
| 362 | OMGA | Omega Therapeutics, Inc. | 125.20M | -3.40% | 251,917 | 3.09M |
| 363 | COYA | Coya Therapeutics, Inc. | 125.07M | 2.02% | 25,203 | 6.00M |
| 364 | MCRB | Seres Therapeutics, Inc. | 124.58M | 11.08% | 3,864,172 | 126.33M |
| 365 | SEER | Seer, Inc. | 123.72M | 9.14% | 954,516 | 16.66M |
| 366 | KPTI | Karyopharm Therapeutics Inc. | 123.45M | - | 652,441 | 146.03M |
| 367 | BCAB | BioAtla, Inc. | 122.17M | 12.89% | 293,467 | - |
| 368 | PDSB | PDS Biotechnology Corporation | 119.94M | 0.31% | 414,341 | - |
| 369 | AMLX | Amylyx Pharmaceuticals, Inc. | 119.69M | -1.12% | 5,198,611 | 380.79M |
| 370 | RLMD | Relmada Therapeutics, Inc. | 115.57M | 3.51% | 80,013 | - |
| 371 | NVCT | Nuvectis Pharma, Inc. | 115.50M | -0.15% | 20,996 | - |
| 372 | VOR | Vor Biopharma Inc. | 115.28M | -0.59% | 152,787 | - |
| 373 | ELYM | Eliem Therapeutics, Inc. | 110.32M | 17.40% | 580,036 | - |
| 374 | IMUX | Immunic, Inc. | 109.71M | -3.17% | 235,121 | - |
| 375 | CTMX | CytomX Therapeutics, Inc. | 107.68M | -0.63% | 248,783 | 101.21M |
| 376 | RZLT | Rezolute, Inc. | 106.74M | 2.31% | 202,569 | - |
| 377 | LIFE | aTyr Pharma, Inc. | 106.37M | -1.57% | 238,673 | 353.00K |
| 378 | CTXR | Citius Pharmaceuticals, Inc. | 105.77M | -9.25% | 2,767,284 | - |
| 379 | GLYC | GlycoMimetics, Inc. | 105.70M | -4.09% | 964,405 | 10.00K |
| 380 | SGMO | Sangamo Therapeutics, Inc. | 105.46M | 2.94% | 650,391 | 176.23M |
| 381 | ADAG | Adagene Inc. | 105.44M | 1.70% | 24,118 | 18.11M |
| 382 | ANIX | Anixa Biosciences, Inc. | 103.04M | 8.39% | 231,810 | 210.00K |
| 383 | FGEN | FibroGen, Inc. | 102.72M | 1.96% | 643,795 | 147.75M |
| 384 | VIGL | Vigil Neuroscience, Inc. | 101.85M | 5.04% | 45,740 | - |
| 385 | CLSD | Clearside Biomedical, Inc. | 100.13M | 6.35% | 153,377 | 8.23M |
| 386 | ARMP | Armata Pharmaceuticals, Inc. | 99.77M | 9.06% | 9,508 | 4.53M |
| 387 | EPRX | Eupraxia Pharmaceuticals Inc. | 99.74M | -1.75% | 10,574 | - |
| 388 | ORMP | Oramed Pharmaceuticals Inc. | 99.68M | 6.96% | 84,376 | 1.34M |
| 389 | CLRB | Cellectar Biosciences, Inc. | 97.75M | 0.33% | 686,302 | - |
| 390 | DMAC | DiaMedica Therapeutics Inc. | 97.55M | 1.58% | 7,704 | - |
| 391 | BTAI | BioXcel Therapeutics, Inc. | 97.40M | 0.77% | 259,485 | 1.38M |
| 392 | BRNS | Barinthus Biotherapeutics plc | 96.61M | -1.57% | 6,863 | 802.00K |
| 393 | IOBT | IO Biotech, Inc. | 93.55M | -3.45% | 73,358 | - |
| 394 | ELTX | Elicio Therapeutics, Inc. | 91.89M | -1.21% | 36,785 | - |
| 395 | GNLX | Genelux Corporation | 91.34M | 2.41% | 84,994 | 170.00K |
| 396 | ALVR | AlloVir, Inc. | 90.92M | -0.36% | 196,060 | - |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 90.03M | 2.34% | 334,030 | - |
| 398 | ALLK | Allakos Inc. | 89.63M | 0.99% | 425,132 | - |
| 399 | VANI | Vivani Medical, Inc. | 89.61M | -3.83% | 110,265 | - |
| 400 | ABEO | Abeona Therapeutics Inc. | 89.18M | 2.19% | 1,190,314 | 3.50M |
| 401 | GRTS | Gritstone bio, Inc. | 86.54M | 6.40% | 1,100,052 | 16.34M |
| 402 | HOOK | HOOKIPA Pharma Inc. | 86.25M | 10.82% | 2,863,483 | 20.13M |
| 403 | CRIS | Curis, Inc. | 85.29M | -0.34% | 10,913 | 10.02M |
| 404 | ALRN | Aileron Therapeutics, Inc. | 84.86M | -1.19% | 85,369 | - |
| 405 | PLX | Protalix BioTherapeutics, Inc. | 84.01M | -2.54% | 954,050 | 65.49M |
| 406 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 83.48M | 0.34% | 115,227 | - |
| 407 | LPTX | Leap Therapeutics, Inc. | 83.21M | 2.52% | 403,126 | - |
| 408 | BYSI | BeyondSpring Inc. | 83.10M | -6.17% | 33,635 | 1.55M |
| 409 | TCON | TRACON Pharmaceuticals, Inc. | 82.36M | 1.12% | 203,995 | 12.05M |
| 410 | ATRA | Atara Biotherapeutics, Inc. | 82.36M | -1.40% | 519,733 | 8.57M |
| 411 | ONCY | Oncolytics Biotech Inc. | 82.21M | 0.93% | 218,934 | - |
| 412 | SLS | SELLAS Life Sciences Group, Inc. | 82.15M | -3.95% | 1,279,322 | - |
| 413 | MIST | Milestone Pharmaceuticals Inc. | 81.85M | -3.14% | 469,654 | 1.00M |
| 414 | PASG | Passage Bio, Inc. | 81.33M | 8.20% | 75,400 | - |
| 415 | CMRX | Chimerix, Inc. | 80.28M | 1.00% | 225,996 | 324.00K |
| 416 | SPRO | Spero Therapeutics, Inc. | 78.68M | 2.10% | 164,571 | 103.78M |
| 417 | TPST | Tempest Therapeutics, Inc. | 78.56M | 1.72% | 401,127 | - |
| 418 | TLSA | Tiziana Life Sciences Ltd | 78.47M | -8.22% | 246,148 | - |
| 419 | IFRX | InflaRx N.V. | 78.31M | -4.32% | 169,301 | 70.10K |
| 420 | CVM | CEL-SCI Corporation | 77.73M | -0.69% | 135,537 | - |
| 421 | MRNS | Marinus Pharmaceuticals, Inc. | 76.77M | -1.06% | 1,110,350 | 30.99M |
| 422 | AFMD | Affimed N.V. | 76.59M | 3.07% | 48,436 | 9.19M |
| 423 | CGTX | Cognition Therapeutics, Inc. | 76.05M | - | 55,055 | - |
| 424 | CNTB | Connect Biopharma Holdings Limited | 73.84M | -0.74% | 58,129 | - |
| 425 | ATHA | Athira Pharma, Inc. | 73.59M | - | 164,543 | - |
| 426 | PALI | Palisade Bio, Inc. | 73.39M | -2.89% | 260,003 | 250.00K |
| 427 | LVTX | LAVA Therapeutics N.V. | 71.77M | 3.41% | 49,922 | 7.52M |
| 428 | CRVS | Corvus Pharmaceuticals, Inc. | 71.11M | -2.03% | 124,234 | - |
| 429 | ENTX | Entera Bio Ltd. | 70.25M | -1.00% | 118,762 | - |
| 430 | LABP | Landos Biopharma, Inc. | 70.17M | - | 8,493 | - |
| 431 | ANEB | Anebulo Pharmaceuticals, Inc. | 70.11M | 1.26% | 373 | - |
| 432 | ASMB | Assembly Biosciences, Inc. | 69.36M | -5.31% | 29,386 | - |
| 433 | ANTX | AN2 Therapeutics, Inc. | 69.07M | 1.75% | 120,570 | - |
| 434 | TIL | Instil Bio, Inc. | 68.94M | 2.02% | 6,550 | - |
| 435 | CSBR | Champions Oncology, Inc. | 68.24M | -0.79% | 1,619 | 49.22M |
| 436 | CARM | Carisma Therapeutics, Inc. | 68.13M | - | 53,447 | 14.92M |
| 437 | CLGN | CollPlant Biotechnologies Ltd. | 67.47M | 7.48% | 5,872 | 10.96M |
| 438 | CUE | Cue Biopharma, Inc. | 66.40M | -3.19% | 261,676 | 5.49M |
| 439 | CELU | Celularity Inc. | 65.78M | -1.63% | 48,969 | 14.79M |
| 440 | VTVT | vTv Therapeutics Inc. | 65.60M | 2.18% | 2,282 | - |
| 441 | DTIL | Precision BioSciences, Inc. | 64.87M | -3.50% | 28,349 | 48.73M |
| 442 | RLYB | Rallybio Corporation | 64.28M | 3.03% | 238,145 | - |
| 443 | MNOV | MediciNova, Inc. | 64.25M | -0.76% | 6,442 | 1.00M |
| 444 | TSBX | Turnstone Biologics Corp. | 63.83M | -4.83% | 129,466 | 19.31M |
| 445 | IKNA | Ikena Oncology, Inc. | 62.74M | -0.76% | 120,388 | 9.16M |
| 446 | MURA | Mural Oncology plc | 60.58M | 1.42% | 95,645 | - |
| 447 | EQ | Equillium, Inc. | 60.29M | -5.52% | 80,121 | 36.08M |
| 448 | KRON | Kronos Bio, Inc. | 60.10M | 2.04% | 437,687 | 6.29M |
| 449 | THTX | Theratechnologies Inc. | 59.77M | - | 12,621 | 57.85M |
| 450 | LTRN | Lantern Pharma Inc. | 59.08M | 0.73% | 128,678 | - |
| 451 | KZR | Kezar Life Sciences, Inc. | 58.60M | 1.89% | 492,116 | 7.00M |
| 452 | CDTX | Cidara Therapeutics, Inc. | 57.61M | -2.85% | 199,096 | 63.91M |
| 453 | BLRX | BioLineRx Ltd. | 57.43M | 6.31% | 581,327 | 4.80M |
| 454 | ALGS | Aligos Therapeutics, Inc. | 56.75M | -4.40% | 110,399 | 15.53M |
| 455 | IMMX | Immix Biopharma, Inc. | 56.22M | 1.43% | 84,671 | - |
| 456 | RPHM | Reneo Pharmaceuticals, Inc. | 55.63M | 1.21% | 114,543 | - |
| 457 | MLEC | Moolec Science SA | 54.47M | 2.11% | 300,700 | 2.90M |
| 458 | AVRO | AVROBIO, Inc. | 54.28M | 2.11% | 204,675 | - |
| 459 | INTS | Intensity Therapeutics, Inc. | 53.81M | 2.75% | 8,191 | - |
| 460 | HCWB | HCW Biologics Inc. | 52.95M | -5.41% | 2,442 | 560.36K |
| 461 | XRTX | XORTX Therapeutics Inc. | 52.71M | 13.13% | 25,019 | - |
| 462 | ABIO | ARCA biopharma, Inc. | 51.91M | 2.87% | 85,281 | - |
| 463 | CKPT | Checkpoint Therapeutics, Inc. | 50.03M | 0.70% | 523,065 | 103.00K |
| 464 | ELDN | Eledon Pharmaceuticals, Inc. | 49.85M | 1.98% | 81,544 | - |
| 465 | JAGX | Jaguar Health, Inc. | 49.72M | 5.88% | 42,904,521 | 9.76M |
| 466 | GANX | Gain Therapeutics, Inc. | 49.15M | -1.30% | 176,310 | 55.18K |
| 467 | GNTA | Genenta Science S.p.A. | 47.18M | -7.51% | 8,093 | - |
| 468 | OCEA | Ocean Biomedical, Inc. | 46.43M | 6.77% | 244,393 | - |
| 469 | OKYO | OKYO Pharma Limited | 45.90M | 6.21% | 11,675 | - |
| 470 | QNCX | Quince Therapeutics, Inc. | 45.81M | 2.91% | 119,373 | - |
| 471 | INAB | IN8bio, Inc. | 45.02M | - | 55,917 | - |
| 472 | MTNB | Matinas BioPharma Holdings, Inc. | 44.87M | -1.43% | 1,391,200 | 1.10M |
| 473 | CLNN | Clene Inc. | 43.65M | -1.90% | 116,812 | 654.00K |
| 474 | DYAI | Dyadic International, Inc. | 43.17M | - | 12,710 | 2.90M |
| 475 | IMRX | Immuneering Corporation | 43.05M | 2.80% | 294,601 | - |
| 476 | AADI | Aadi Bioscience, Inc. | 42.97M | 4.17% | 147,008 | 24.35M |
| 477 | BOLT | Bolt Biotherapeutics, Inc. | 42.32M | -3.48% | 122,267 | 7.88M |
| 478 | APLM | Apollomics, Inc. | 40.27M | -7.98% | 244,886 | - |
| 479 | XLO | Xilio Therapeutics, Inc. | 40.23M | 7.92% | 143,939 | - |
| 480 | CTCX | Carmell Therapeutics Corporation | 40.22M | 2.45% | 439 | - |
| 481 | MAIA | MAIA Biotechnology, Inc. | 40.06M | 9.70% | 436,229 | - |
| 482 | OCUP | Ocuphire Pharma, Inc. | 39.95M | 4.89% | 113,234 | 19.05M |
| 483 | ICCC | ImmuCell Corporation | 39.84M | -0.98% | 1,776 | 17.47M |
| 484 | SABS | SAB Biotherapeutics, Inc. | 39.21M | 4.59% | 4,877 | 2.24M |
| 485 | MRKR | Marker Therapeutics, Inc. | 38.19M | -4.02% | 12,555 | 3.31M |
| 486 | NXTC | NextCure, Inc. | 37.76M | 4.65% | 56,503 | - |
| 487 | PMN | ProMIS Neurosciences, Inc. | 37.54M | -2.46% | 1,029 | - |
| 488 | CARA | Cara Therapeutics, Inc. | 37.41M | -2.24% | 166,584 | 20.97M |
| 489 | ESLA | Estrella Immunopharma, Inc. | 37.34M | -0.97% | 14,302 | - |
| 490 | NRXP | NRx Pharmaceuticals, Inc. | 37.13M | 12.74% | 275,522 | - |
| 491 | NKGN | NKGen Biotech, Inc. | 36.72M | -18.69% | 543,605 | - |
| 492 | BCLI | Brainstorm Cell Therapeutics Inc. | 36.53M | 0.47% | 264,465 | - |
| 493 | UNCY | Unicycive Therapeutics, Inc. | 35.80M | 6.19% | 231,136 | - |
| 494 | VYNE | VYNE Therapeutics Inc. | 35.25M | 1.21% | 15,849 | 424.00K |
| 495 | IPA | ImmunoPrecise Antibodies Ltd. | 34.74M | 8.20% | 102,213 | 17.67M |
| 496 | BCTX | BriaCell Therapeutics Corp. | 34.68M | - | 36,056 | - |
| 497 | TARA | Protara Therapeutics, Inc. | 33.44M | -4.10% | 254,929 | - |
| 498 | FBIO | Fortress Biotech, Inc. | 33.08M | - | 103,317 | 84.51M |
| 499 | ACXP | Acurx Pharmaceuticals, Inc. | 32.62M | 2.48% | 28,594 | - |
| 500 | VIRX | Viracta Therapeutics, Inc. | 32.53M | -2.21% | 35,904 | - |
| 501 | CASI | CASI Pharmaceuticals, Inc. | 32.43M | 5.22% | 3,428 | 33.88M |
| 502 | INKT | MiNK Therapeutics, Inc. | 32.18M | 6.46% | 30,265 | - |
| 503 | EYEN | Eyenovia, Inc. | 31.79M | -11.68% | 1,591,945 | 3.79K |
| 504 | EVGN | Evogene Ltd. | 31.62M | -5.54% | 80,002 | 5.64M |
| 505 | ACHL | Achilles Therapeutics plc | 31.22M | -2.69% | 381,717 | - |
| 506 | DARE | Daré Bioscience, Inc. | 30.77M | 5.77% | 170,718 | 2.81M |
| 507 | IGC | IGC Pharma Inc | 30.48M | 6.51% | 771,982 | 1.22M |
| 508 | PTN | Palatin Technologies, Inc. | 29.37M | 5.81% | 118,445 | 7.10M |
| 509 | LEXX | Lexaria Bioscience Corp. | 29.09M | 7.31% | 172,105 | 386.00K |
| 510 | SPRB | Spruce Biosciences, Inc. | 28.80M | -0.14% | 194,678 | 10.09M |
| 511 | SRZN | Surrozen, Inc. | 28.72M | -2.32% | 11,124 | - |
| 512 | ICU | SeaStar Medical Holding Corporation | 28.68M | -8.63% | 1,689,970 | - |
| 513 | APRE | Aprea Therapeutics, Inc. | 28.24M | -2.07% | 4,734 | 583.23K |
| 514 | NTRB | Nutriband Inc. | 27.81M | 3.85% | 10,264 | 2.09M |
| 515 | PLUR | Pluri Inc. | 27.78M | 2.23% | 6,843 | 357.00K |
| 516 | ITRM | Iterum Therapeutics plc | 27.43M | 0.64% | 106,471 | - |
| 517 | ACST | Acasti Pharma Inc. | 27.26M | -5.07% | 3,820 | - |
| 518 | ENLV | Enlivex Therapeutics Ltd. | 26.77M | -0.69% | 57,998 | - |
| 519 | BIVI | BioVie Inc. | 26.63M | -0.84% | 310,140 | - |
| 520 | FBRX | Forte Biosciences, Inc. | 26.07M | -0.07% | 5,705 | - |
| 521 | SNSE | Sensei Biotherapeutics, Inc. | 25.57M | -1.92% | 6,144 | - |
| 522 | LPCN | Lipocine Inc. | 25.50M | 6.15% | 19,174 | -2.85M |
| 523 | UBX | Unity Biotechnology, Inc. | 25.18M | 1.35% | 38,469 | - |
| 524 | SLGL | Sol-Gel Technologies Ltd. | 24.78M | -4.38% | 3,055 | 1.55M |
| 525 | ONCT | Oncternal Therapeutics, Inc. | 24.54M | 6.09% | 1,435 | 785.00K |
| 526 | GDTC | CytoMed Therapeutics Limited | 24.21M | -2.33% | 1,760 | - |
| 527 | ADXN | Addex Therapeutics Ltd | 23.20M | 4.48% | 21,438 | 1.96M |
| 528 | SER | Serina Therapeutics Inc | 22.98M | -8.09% | 1,530 | 142.00K |
| 529 | BIOR | Biora Therapeutics, Inc. | 22.52M | 3.41% | 127,941 | 4.00K |
| 530 | CNTX | Context Therapeutics Inc. | 22.51M | 0.71% | 19,946 | - |
| 531 | LUMO | Lumos Pharma, Inc. | 22.46M | 2.14% | 681 | 2.05M |
| 532 | APM | Aptorum Group Limited | 22.02M | -3.65% | 27,122 | 1.20M |
| 533 | LSTA | Lisata Therapeutics, Inc. | 22.00M | 1.46% | 4,674 | - |
| 534 | EVAX | Evaxion Biotech A/S | 21.80M | 1.46% | 24,736 | 73.00K |
| 535 | SYBX | Synlogic, Inc. | 21.78M | -1.06% | 3,839 | 3.37M |
| 536 | NRXS | NeurAxis, Inc. | 21.43M | 8.33% | 4,705 | 2.46M |
| 537 | AIM | AIM ImmunoTech Inc. | 21.37M | 5.34% | 82,199 | 202.00K |
| 538 | NRSN | NeuroSense Therapeutics Ltd. | 21.32M | -2.38% | 42,255 | - |
| 539 | TCRT | Alaunos Therapeutics, Inc. | 21.14M | 13.79% | 50,937 | 5.00K |
| 540 | RNXT | RenovoRx, Inc. | 20.96M | - | 27,794 | - |
| 541 | ATHE | Alterity Therapeutics Limited | 20.57M | 9.61% | 87,711 | - |
| 542 | MEIP | MEI Pharma, Inc. | 20.32M | -1.61% | 8,002 | 72.65M |
| 543 | PHGE | BiomX Inc. | 19.33M | 4.17% | 159,301 | - |
| 544 | APTO | Aptose Biosciences Inc. | 19.18M | 5.17% | 104,740 | - |
| 545 | GLTO | Galecto, Inc. | 19.11M | 5.62% | 119,396 | - |
| 546 | INDP | Indaptus Therapeutics, Inc. | 18.02M | -3.21% | 8,071 | - |
| 547 | BNTC | Benitec Biopharma Inc. | 17.89M | -0.14% | 19,742 | 61.00K |
| 548 | PMCB | PharmaCyte Biotech, Inc. | 17.86M | -1.40% | 5,596 | - |
| 549 | KALA | Kala Pharmaceuticals, Inc. | 17.74M | 1.78% | 5,709 | - |
| 550 | ORGS | Orgenesis Inc. | 17.41M | -3.88% | 24,462 | 530.00K |
| 551 | NERV | Minerva Neurosciences, Inc. | 17.04M | -0.55% | 4,130 | - |
| 552 | IMRN | Immuron Limited | 16.90M | 5.66% | 9,564 | 2.43M |
| 553 | AVTX | Avalo Therapeutics, Inc. | 16.48M | 6.41% | 78,100 | 1.92M |
| 554 | VBIV | VBI Vaccines Inc. | 16.32M | -4.24% | 183,338 | 8.68M |
| 555 | DOMH | Dominari Holdings Inc. | 16.02M | -2.95% | 16,309 | 2.04M |
| 556 | COCP | Cocrystal Pharma, Inc. | 15.82M | 2.30% | 29,490 | - |
| 557 | TRAW | Traws Pharma Inc | 15.70M | 1.22% | 44,451 | 226.00K |
| 558 | VINC | Vincerx Pharma, Inc. | 15.63M | -18.59% | 1,703,149 | - |
| 559 | NRBO | NeuroBo Pharmaceuticals, Inc. | 15.40M | 2.61% | 16,901 | - |
| 560 | ABVC | ABVC BioPharma, Inc. | 15.00M | -10.69% | 2,003,930 | 152.43K |
| 561 | IBIO | iBio, Inc. | 14.99M | 2.33% | 60,084 | 50.00K |
| 562 | CDIO | Cardio Diagnostics Holdings, Inc. | 14.90M | -4.49% | 446,340 | 17.07K |
| 563 | VAXX | Vaxxinity, Inc. | 14.78M | -3.95% | 1,928,956 | - |
| 564 | PIRS | Pieris Pharmaceuticals, Inc. | 14.49M | 1.03% | 16,948 | 42.81M |
| 565 | TNXP | Tonix Pharmaceuticals Holding Corp. | 14.24M | 5.31% | 1,820,296 | 7.77M |
| 566 | FRES | Fresh2 Group Ltd | 14.20M | -3.55% | 135,472 | 2.35M |
| 567 | EDSA | Edesa Biotech, Inc. | 14.02M | - | 2,291 | - |
| 568 | IMNN | Imunon, Inc. | 13.54M | - | 43,785 | - |
| 569 | SNTI | Senti Biosciences, Inc. | 13.27M | 4.05% | 44,695 | 2.56M |
| 570 | XTLB | XTL Biopharmaceuticals Ltd. | 13.20M | 0.92% | 5,242 | - |
| 571 | NNVC | NanoViricides, Inc. | 12.96M | -0.90% | 5,659 | - |
| 572 | PPBT | Purple Biotech Ltd. | 12.74M | -1.00% | 172,012 | - |
| 573 | KPRX | Kiora Pharmaceuticals, Inc. | 12.34M | -2.08% | 117,032 | - |
| 574 | MNPR | Monopar Therapeutics Inc. | 11.49M | 4.81% | 34,550 | - |
| 575 | ELAB | Elevai Labs, Inc. | 11.42M | -2.21% | 153,323 | 1.71M |
| 576 | COEP | Coeptis Therapeutics, Inc. | 11.42M | 3.98% | 52,424 | - |
| 577 | IKT | Inhibikase Therapeutics, Inc. | 11.08M | -8.60% | 98,979 | 260.50K |
| 578 | CANF | Can-Fite BioPharma Ltd. | 10.85M | 3.13% | 8,643 | 743.00K |
| 579 | BNOX | Bionomics Limited | 10.69M | 3.49% | 43,731 | 15.00K |
| 580 | GRTX | Galera Therapeutics, Inc. | 10.12M | -10.31% | 2,109,375 | - |
| 581 | BCDA | BioCardia, Inc. | 10.12M | 2.95% | 29,240 | 477.00K |
| 582 | ONVO | Organovo Holdings, Inc. | 10.04M | 1.20% | 139,329 | 242.00K |
| 583 | MBRX | Moleculin Biotech, Inc. | 9.81M | - | 1,247 | - |
| 584 | ERNA | Eterna Therapeutics Inc. | 9.68M | 3.47% | 15,060 | 68.00K |
| 585 | CMMB | Chemomab Therapeutics Ltd. | 9.51M | -2.90% | 23,537 | - |
| 586 | AEZS | Aeterna Zentaris Inc. | 9.50M | -1.71% | 5,085 | 4.50M |
| 587 | CHRO | Chromocell Therapeutics Corp | 9.40M | 6.47% | 26,702 | - |
| 588 | KZIA | Kazia Therapeutics Limited | 9.20M | 1.48% | 55,078 | 15.65K |
| 589 | MTEM | Molecular Templates, Inc. | 9.16M | 7.23% | 68,803 | 57.31M |
| 590 | VIRI | Virios Therapeutics, Inc. | 9.04M | 1.65% | 38,251 | - |
| 591 | NTBL | Notable Labs, Ltd. | 8.70M | -0.27% | 140,970 | 310.00K |
| 592 | BRTX | BioRestorative Therapies, Inc. | 8.46M | 1.63% | 57,563 | 145.80K |
| 593 | NCNA | NuCana plc | 8.38M | 4.17% | 6,746 | - |
| 594 | LGVN | Longeveron Inc. | 8.35M | 4.79% | 369,710 | 709.00K |
| 595 | VCNX | Vaccinex, Inc. | 8.31M | -1.02% | 12,339 | 570.00K |
| 596 | KTRA | Kintara Therapeutics, Inc. | 8.23M | -5.82% | 50,979,698 | - |
| 597 | CYCN | Cyclerion Therapeutics, Inc. | 7.94M | -6.69% | 274 | - |
| 598 | CLDI | Calidi Biotherapeutics, Inc. | 7.87M | 0.44% | 874,140 | - |
| 599 | PYPD | PolyPid Ltd. | 7.86M | 4.46% | 2,320 | - |
| 600 | AKTX | Akari Therapeutics, Plc | 7.84M | 1.28% | 11,302 | - |
| 601 | KTTA | Pasithea Therapeutics Corp. | 7.55M | 3.43% | 278 | - |
| 602 | HEPA | Hepion Pharmaceuticals, Inc. | 7.50M | 6.20% | 39,592 | - |
| 603 | PULM | Pulmatrix, Inc. | 7.45M | -1.45% | 6,759 | 7.30M |
| 604 | TFFP | TFF Pharmaceuticals, Inc. | 7.36M | -5.45% | 34,013 | 733.87K |
| 605 | LIXT | Lixte Biotechnology Holdings, Inc. | 7.33M | 0.31% | 4,160 | - |
| 606 | ASLN | ASLAN Pharmaceuticals Limited | 7.31M | -7.30% | 650,371 | 12.00M |
| 607 | PSTV | Plus Therapeutics, Inc. | 7.23M | 1.81% | 16,423 | 4.91M |
| 608 | TOVX | Theriva Biologics, Inc. | 7.19M | 2.33% | 168,523 | - |
| 609 | EFTR | eFFECTOR Therapeutics, Inc. | 6.97M | 4.42% | 161,694 | - |
| 610 | CVKD | Cadrenal Therapeutics, Inc. | 6.89M | -0.61% | 81,231 | - |
| 611 | TENX | Tenax Therapeutics, Inc. | 6.81M | -0.85% | 16,489 | - |
| 612 | KA | Kineta, Inc. | 6.69M | -2.37% | 130,576 | 5.44M |
| 613 | ADIL | Adial Pharmaceuticals, Inc. | 6.53M | -6.94% | 242,647 | - |
| 614 | ENVB | Enveric Biosciences, Inc. | 6.53M | -2.45% | 45,688 | - |
| 615 | TTNP | Titan Pharmaceuticals, Inc. | 6.48M | 0.57% | 10,646 | 184.00K |
| 616 | XBIO | Xenetic Biosciences, Inc. | 6.30M | 8.49% | 807 | 2.54M |
| 617 | AZTR | Azitra, Inc. | 6.29M | - | 291,046 | 686.00K |
| 618 | PTIX | Protagenic Therapeutics, Inc. | 6.14M | -4.48% | 10,464 | - |
| 619 | PCSA | Processa Pharmaceuticals, Inc. | 6.14M | -11.52% | 1,825,716 | - |
| 620 | MYMD | MyMD Pharmaceuticals, Inc. | 6.13M | 0.36% | 17,428 | - |
| 621 | SCPX | Scorpius Holdings, Inc. | 6.09M | 3.49% | 305,860 | 2.23M |
| 622 | TRVN | Trevena, Inc. | 5.93M | -0.88% | 45,934 | 3.13M |
| 623 | CELZ | Creative Medical Technology Holdings, Inc. | 5.86M | -2.26% | 11,154 | 9.00K |
| 624 | HOTH | Hoth Therapeutics, Inc. | 5.67M | - | 48,634 | - |
| 625 | SNGX | Soligenix, Inc. | 5.67M | -2.81% | 263,370 | 839.36K |
| 626 | FWBI | First Wave BioPharma, Inc. | 5.55M | 0.37% | 44,592 | - |
| 627 | PXMD | PaxMedica, Inc. | 5.52M | 5.06% | 494,828 | - |
| 628 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 5.43M | 1.14% | 9,532 | 129.18K |
| 629 | NLSP | NLS Pharmaceutics AG | 5.41M | 3.25% | 438,787 | - |
| 630 | SILO | Silo Pharma, Inc. | 5.26M | -2.63% | 55,867 | 72.10K |
| 631 | ALZN | Alzamend Neuro, Inc. | 4.94M | -0.90% | 13,819 | - |
| 632 | SNPX | Synaptogenix, Inc. | 4.92M | 2.72% | 6,874 | - |
| 633 | PRTG | Portage Biotech Inc. | 4.75M | 0.91% | 62,925 | - |
| 634 | DRUG | Bright Minds Biosciences Inc. | 4.75M | - | 6,013 | - |
| 635 | ADTX | Aditxt, Inc. | 4.69M | -5.53% | 65,262 | 645.18K |
| 636 | NEXI | NexImmune, Inc. | 4.62M | -1.17% | 3,523 | - |
| 637 | GTBP | GT Biopharma, Inc. | 4.62M | -7.63% | 10,324 | - |
| 638 | OGEN | Oragenics, Inc. | 4.62M | -0.94% | 43,118 | 37.65K |
| 639 | ZVSA | ZyVersa Therapeutics, Inc. | 4.54M | -16.83% | 433,962 | - |
| 640 | LIPO | Lipella Pharmaceuticals Inc. | 4.44M | 0.98% | 4,096 | 449.62K |
| 641 | THAR | Tharimmune, Inc. | 4.33M | 2.47% | 62,050 | - |
| 642 | XCUR | Exicure, Inc. | 4.33M | -0.73% | 28,216 | 23.79M |
| 643 | ARTL | Artelo Biosciences, Inc. | 4.32M | -0.75% | 4,785 | - |
| 644 | ENSC | Ensysce Biosciences, Inc. | 4.28M | 1.69% | 176,491 | - |
| 645 | ATXI | Avenue Therapeutics, Inc. | 4.28M | -29.35% | 225,631 | - |
| 646 | GNPX | Genprex, Inc. | 4.22M | 1.42% | 23,115 | - |
| 647 | BPTH | Bio-Path Holdings, Inc. | 4.20M | 1.71% | 117,094 | - |
| 648 | SEEL | Seelos Therapeutics, Inc. | 3.98M | 1.89% | 556,743 | 2.20M |
| 649 | CYTO | Altamira Therapeutics Ltd. | 3.79M | 5.62% | 165,623 | - |
| 650 | FNCH | Finch Therapeutics Group, Inc. | 3.73M | 3.11% | 37,427 | 107.00K |
| 651 | CMND | Clearmind Medicine Inc. | 3.68M | -2.52% | 23,104 | - |
| 652 | VRPX | Virpax Pharmaceuticals, Inc. | 3.63M | 8.01% | 5,194 | - |
| 653 | RNAZ | TransCode Therapeutics, Inc. | 3.61M | 1.11% | 692,659 | - |
| 654 | REVB | Revelation Biosciences, Inc. | 3.56M | 1.89% | 45,510 | - |
| 655 | CING | Cingulate Inc. | 3.50M | 1.71% | 8,615 | - |
| 656 | MBIO | Mustang Bio, Inc. | 3.28M | -11.58% | 253,043 | - |
| 657 | GOVX | GeoVax Labs, Inc. | 3.28M | -3.40% | 37,441 | - |
| 658 | SPRC | SciSparc Ltd. | 3.24M | 4.76% | 189,640 | 2.88M |
| 659 | PHIO | Phio Pharmaceuticals Corp. | 3.13M | 1.34% | 105,880 | - |
| 660 | NBY | NovaBay Pharmaceuticals, Inc. | 2.84M | 2.34% | 2,482,842 | 14.73M |
| 661 | BPTS | Biophytis S.A. | 2.82M | - | 17,954 | - |
| 662 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.75M | -0.50% | 84,104 | 253.57K |
| 663 | WINT | Windtree Therapeutics, Inc. | 2.67M | 2.55% | 28,356 | - |
| 664 | ONCO | Onconetix, Inc. | 2.60M | -3.24% | 156,180 | 58.47K |
| 665 | SLRX | Salarius Pharmaceuticals, Inc. | 2.36M | 2.93% | 3,017 | - |
| 666 | GLMD | Galmed Pharmaceuticals Ltd. | 2.35M | 0.90% | 27,046 | - |
| 667 | CNSP | CNS Pharmaceuticals, Inc. | 2.29M | 2.87% | 107,836 | - |
| 668 | DRMA | Dermata Therapeutics, Inc. | 2.28M | -5.34% | 16,646 | - |
| 669 | SCNI | Scinai Immunotherapeutics Ltd. | 1.99M | 1.73% | 4,800 | - |
| 670 | CYCC | Cyclacel Pharmaceuticals, Inc. | 1.99M | -5.63% | 179,950 | 420.00K |
| 671 | QLGN | Qualigen Therapeutics, Inc. | 1.83M | -4.50% | 9,087 | - |
| 672 | NBSE | NeuBase Therapeutics, Inc. | 1.65M | -0.54% | 72,156 | - |
| 673 | VRAX | Virax Biolabs Group Limited | 1.63M | -5.13% | 3,027 | 79.30K |
| 674 | ATNF | 180 Life Sciences Corp. | 1.53M | 4.05% | 20,355 | - |
| 675 | TCBP | TC Biopharm (Holdings) Plc | 1.47M | -2.55% | 71,243 | - |
| 676 | INM | InMed Pharmaceuticals Inc. | 1.39M | -7.27% | 471,617 | 5.49M |
| 677 | GRI | GRI Bio, Inc. | 1.37M | -1.35% | 62,039 | - |
| 678 | ALLR | Allarity Therapeutics, Inc. | 687.91K | 2.10% | 185,447 | - |
| 679 | QNRX | Quoin Pharmaceuticals, Ltd. | 629.35K | 0.79% | 54,899 | - |
| 680 | APVO | Aptevo Therapeutics Inc. | 475.51K | 3.84% | 169,781 | - |
| 681 | BDRX | Biodexa Pharmaceuticals Plc | 307.46K | 80.56% | 70,092,348 | 482.28K |